<p>Acute and late toxicities following intensity-modulated and image-guided radiotherapy for 27 patients with locally advanced laryngeal cancer.</p
For patients with unresectable locally-advanced non-small cell lung cancer (LA-NSCLC), concurrent ch...
The study aims to assess the feasibility of intensity-modulated and image-guided radiotherapy (IMRT,...
A randomized trial was initiated to investigate whether a reduction of the dose to the elective noda...
a<p>Radiotherapy-related late toxicities were defined in patients whose follow-up period was over on...
Radiotherapy is used in >50% of patients with cancer, both for curative and palliative purposes. ...
Introduction: Combined modality therapy is the standard of care in locally advanced head-and-neck ca...
<p>Grade 3 acute toxicity during and up to 6 months after radiotherapy, and late treatment-related t...
Purpose To investigate the impact of treatment-related toxicity on health-related quality of life (H...
peer reviewedHaving previously quantified late effects of a split-course hypofractionated radiothera...
Radiotherapy (RT) is used to treat approximately 80% of patients with cancer of the head and neck. D...
The authors report acute toxicity in 14 patients with locally advanced head and neck squamous cell c...
Background and purpose: A comprehensive individual toxicity risk profile is needed to improve radiat...
Background and purpose: A comprehensive individual toxicity risk profile is needed to improve radiat...
Background: Conformal radiotherapy modalities may minimize treatment toxicities. The purpose of this...
The study aims to assess the feasibility of intensity-modulated and image-guided radiotherapy (IMRT,...
For patients with unresectable locally-advanced non-small cell lung cancer (LA-NSCLC), concurrent ch...
The study aims to assess the feasibility of intensity-modulated and image-guided radiotherapy (IMRT,...
A randomized trial was initiated to investigate whether a reduction of the dose to the elective noda...
a<p>Radiotherapy-related late toxicities were defined in patients whose follow-up period was over on...
Radiotherapy is used in >50% of patients with cancer, both for curative and palliative purposes. ...
Introduction: Combined modality therapy is the standard of care in locally advanced head-and-neck ca...
<p>Grade 3 acute toxicity during and up to 6 months after radiotherapy, and late treatment-related t...
Purpose To investigate the impact of treatment-related toxicity on health-related quality of life (H...
peer reviewedHaving previously quantified late effects of a split-course hypofractionated radiothera...
Radiotherapy (RT) is used to treat approximately 80% of patients with cancer of the head and neck. D...
The authors report acute toxicity in 14 patients with locally advanced head and neck squamous cell c...
Background and purpose: A comprehensive individual toxicity risk profile is needed to improve radiat...
Background and purpose: A comprehensive individual toxicity risk profile is needed to improve radiat...
Background: Conformal radiotherapy modalities may minimize treatment toxicities. The purpose of this...
The study aims to assess the feasibility of intensity-modulated and image-guided radiotherapy (IMRT,...
For patients with unresectable locally-advanced non-small cell lung cancer (LA-NSCLC), concurrent ch...
The study aims to assess the feasibility of intensity-modulated and image-guided radiotherapy (IMRT,...
A randomized trial was initiated to investigate whether a reduction of the dose to the elective noda...